rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
1
|
pubmed:dateCreated |
2004-1-30
|
pubmed:abstractText |
Limited capability exists to predict when vagus nerve stimulation (VNS) battery deterioration becomes significant. Initial models last 2-5 years. We evaluated the first 18 patients with pharmacoresistent epilepsy after reimplantation to examine the clinical course observed during VNS end of service (EOS).
|
pubmed:commentsCorrections |
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Feb
|
pubmed:issn |
1525-5050
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
5
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
128-32
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:14751218-Adolescent,
pubmed-meshheading:14751218-Adult,
pubmed-meshheading:14751218-Aged,
pubmed-meshheading:14751218-Anticonvulsants,
pubmed-meshheading:14751218-Child,
pubmed-meshheading:14751218-Drug Resistance,
pubmed-meshheading:14751218-Electric Stimulation Therapy,
pubmed-meshheading:14751218-Electroencephalography,
pubmed-meshheading:14751218-Epilepsy,
pubmed-meshheading:14751218-Female,
pubmed-meshheading:14751218-Follow-Up Studies,
pubmed-meshheading:14751218-Humans,
pubmed-meshheading:14751218-Male,
pubmed-meshheading:14751218-Middle Aged,
pubmed-meshheading:14751218-Perception,
pubmed-meshheading:14751218-Prospective Studies,
pubmed-meshheading:14751218-Prostheses and Implants,
pubmed-meshheading:14751218-Questionnaires,
pubmed-meshheading:14751218-Retrospective Studies,
pubmed-meshheading:14751218-Treatment Outcome,
pubmed-meshheading:14751218-Vagus Nerve
|
pubmed:year |
2004
|
pubmed:articleTitle |
Vagus nerve stimulation for pharmacoresistant epilepsy: clinical symptoms with end of service.
|
pubmed:affiliation |
Tampa General Hospital Epilepsy Center, Tampa, FL, USA. wotiv@aol.com
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Comparative Study
|